Table 2 |
||||
|
Patients receiving depleting therapies |
||||
|
Patients |
n |
Agea range (median; years) |
Sex (male/female) |
Graft manipulation |
|
|
||||
|
RA cohort 1 |
9 |
32–61 (42) |
2/7 |
Unmanipulated |
|
RA cohort 2 |
16 |
43–55 (47) |
4/12 |
CD34 selection |
|
RA cohort 3 |
6 |
24–61 (39) |
3/3 |
CD34 selection, T-cell depletion |
|
Solid tumours |
7 |
39–64 (44) |
2/5 |
Unmanipulated |
|
Lymphoma/sarcoma |
7 |
22–64 (46) |
5/2 |
Unmanipulated |
|
Systemic vasculitis (depleting antibody therapy) |
3 |
43–61 (52) |
2/1 |
Not applicable |
|
|
||||
|
aAge at time of transplantation. RA, rheumatoid arthritis. |
||||
|
Ponchel et al. Arthritis Res Ther 2005 7:R80 doi:10.1186/ar1452 |
||||
